Humacyte Stock Forum

$Humacyte (HUMA.US)$ Order 66

$Humacyte (HUMA.US)$ hard 8

$Humacyte (HUMA.US)$
Humacyte and Pluristyx Announce Gene Editing Partnership to Support BioVascular Pancreas (BVP™) Development Using iPSCs
Humacyte (Nasdaq: HUMA) and Pluristyx have expanded their partnership to advance the development of the BioVascular Pancreas (BVP™), designed to treat insulin-dependent diabetes. Pluristyx will provide gene-edited PluriBank™ iPSC lines with blocked Human Leukocyte Antigen (HLA) markers expression, using their clinical-grade Mad7 gene editing technology.
...

$Humacyte (HUMA.US)$ Reuters
1 min ago
Humacyte and Pluristyx Announce Gene Editing Partnership to Support Biovascular Pancreas (Bvp™) Development Using Ipscs

Potentially breaking out from a downward sloping Raff Regression model. I am long $Humacyte (HUMA.US)$ .

$Humacyte (HUMA.US)$ Finally going up for real?

$Humacyte (HUMA.US)$ will it cross $5.1 today

$Humacyte (HUMA.US)$
FDA delay in approving Humacyte stemmed from national security concerns - developed in collaboration with the DoD. An undeniable strategic advantage for the U.S. military.
The fact that we have a +10 billion $ runway is just nice to know.

$HUMA 250117 10.00C$
Fresenius, with its stake and rights in Humacyte, could face a bidding war from Baxter, which seeks to expand its hemodialysis portfolio. Both see Humacyte’s innovative vascular technology as key to dominating the dialysis market.